BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22229322)

  • 1. C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome.
    Banu S; Jabir NR; Manjunath CN; Shakil S; Kamal MA
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):921-7. PubMed ID: 22229322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study.
    Kullenberg H; Rossen J; Johansson UB; Hagströmer M; Nyström T; Kumlin M; Svedberg MM
    Endocrine; 2024 May; 84(2):450-458. PubMed ID: 37980298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Peptide Is a Sensitive Indicator for the Diagnosis of Metabolic Syndrome in Subjects from Central Mexico.
    Gonzalez-Mejia ME; Porchia LM; Torres-Rasgado E; Ruiz-Vivanco G; Pulido-Pérez P; Báez-Duarte BG; Pérez-Fuentes R
    Metab Syndr Relat Disord; 2016 May; 14(4):210-6. PubMed ID: 26863426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
    Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
    Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the insulin resistance and circulating predictive biochemical markers in metabolic syndrome among young adults in western Algeria.
    Belhayara MI; Mellouk Z; Hamdaoui MS; Bachaoui M; Kheroua O; Malaisse WJ
    Diabetes Metab Syndr; 2019; 13(1):504-509. PubMed ID: 30641755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and metabolic syndrome in children of parents with diabetes mellitus.
    Altinli S; Elevli M; Ozkul AA; Kara PG; Karsidag K; Dogru M
    J Pediatr Endocrinol Metab; 2007 Mar; 20(3):431-6. PubMed ID: 17451082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmatic lipocalin-2 levels in chronic low-grade inflammation syndromes: Comparison between metabolic syndrome, total and partial adult growth hormone deficiency.
    Currò D; Vergani E; Bruno C; Comi S; D'Abate C; Mancini A
    Biofactors; 2020 Jul; 46(4):629-636. PubMed ID: 32196782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?
    Liu A; Reaven GM
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1122-7. PubMed ID: 23352957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Muscle Indices with Metabolic Parameters and C-Peptide in Type 2 Diabetes Mellitus.
    Tuzun S; Oner C; Dabak MR; Kasikci HO; Sargin M
    J Coll Physicians Surg Pak; 2017 Nov; 27(11):673-677. PubMed ID: 29132475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.
    Yamamoto Y; Hirose H; Saito I; Tomita M; Taniyama M; Matsubara K; Okazaki Y; Ishii T; Nishikai K; Saruta T
    Clin Sci (Lond); 2002 Aug; 103(2):137-42. PubMed ID: 12149104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Profile in Patients with Mild Obstructive Sleep Apnea.
    Silva LOE; Guimarães TM; Luz GP; Coelho G; Badke L; Almeida IR; Millani-Carneiro A; Tufik S; Bittencourt L; Togeiro SM
    Metab Syndr Relat Disord; 2018 Feb; 16(1):6-12. PubMed ID: 29148894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principal component 1 score calculated from metabolic syndrome diagnostic parameters is a possible marker for the development of metabolic syndrome in middle-aged Japanese men without treatment for metabolic diseases.
    Mochizuki K; Miyauchi R; Misaki Y; Ichikawa Y; Goda T
    Eur J Nutr; 2013 Feb; 52(1):67-74. PubMed ID: 22160241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
    Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
    Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
    Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
    Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
    Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma osteocalcin, glycaemic control and components of metabolic syndrome in adult Nigerians with type 2 diabetes mellitus.
    Onyenekwu CP; Azinge EC; Egbuagha EU; Okpara HC
    Diabetes Metab Syndr; 2017; 11(4):281-286. PubMed ID: 28017632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in drug-nave Chinese patients with insulin-sensitive and insulin-resistant type 2 diabetes.
    Lin JD
    Ann Saudi Med; 2016; 36(3):203-9. PubMed ID: 27236392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.